Sr AD​/Director, Medical Affairs Strategy Team Member; Obesity​/MASH

Sr AD / Director, Medical Affairs Strategy Team Member (Obesity / MASH) Description

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people.

The Senior Associate Director, Medical Affairs Strategy Team Member serves as the subject matter expert to create the indication-specific or product-specific Medical strategic framework and prioritized Medical tactics to ensure the success of the respective BI product(s) from a Medical Affairs perspective, both prior to and leading up to launch as well as throughout the product lifecycle. This individual will bring together strong technical knowledge of the therapeutic area, strong command of the relevant clinical practice guidelines and related scientific data as well as the understanding of the overall TA priorities and value drivers into an integrated strategic medical plan and tactics that enable the successful medical affairs contribution to BI’s portfolio and informs clinical development efforts where applicable.

The incumbent will work with relevant stakeholders to drive integrated medical plans and executable tactics customized for organized customer channels including Health Systems and Payers.

The Senior Associate Director, Medical Affairs Strategy Team Member collaborates cross functionally within the larger Clinical Development & Medical Affairs (CDMA) department (e.g., Medicine Excellence, Field Medical Affairs, RWE, etc.) and across the organization (e.g., Marketing, Market Access, Analytics & Insights (A&I), HEOR, Clinical Operations, Patient Services, Legal, Compliance, etc.) and with global counterparts to create, execute, measure and adapt the Medical Affairs strategy to best fit the needs of the US clinical landscape and market dynamics of relevance to the respective TA.

The Director, Medical Affairs Strategy Team Member is responsible to create the Medical strategic framework and prioritized medical tactics to ensure the success of the respective BI product(s) from a Medical Affairs perspective, both prior to and leading up to launch as well as throughout the product lifecycle. This individual will exhibit strong understanding of the therapeutic area, the US healthcare landscape, the relevant clinical practice guidelines, and the emerging scientific data as well as the understanding of the overall TA aspirations and value drivers.

The position holder will translate the TA priorities into an integrated strategic medical plan, tactics, and well-planned budgets that enable the successful medical affairs contribution to BI’s portfolio. In doing so, this individual will play a key role with corporate stakeholders, the US cross‑functional partners, and the US Launch Teams in leading the co‑creation of aligned strategic medical launch readiness;

and work closely with the clinical development leads to ensure the successful integration of the US Medical insights and efforts where applicable.

The Director, Medical Affairs Strategy Team Member will work with relevant stakeholders to identify the relevant external organized customer channels including the prioritized Health Systems and Payers to drive customized integrated medical plans and executable tactics for this customer segment. The incumbent collaborates cross functionally and within the larger Clinical Development & Medical Affairs (CDMA) department (e.g., Medical Excellence, RWE, etc.)

as well as across the organization (e.g., Marketing, Market Access, Analytics & Insights (A&I), HEOR, Clinical Operations, Patient Services, Legal, Compliance, etc.) and with global counterparts to create, execute, measure, and adapt the Medical Affairs strategy.

• Drives the US collaboration with Corporate TA’s to create a consolidated medical strategy and integrated evidence plan for obesity / MASH products/indications that…